IP Library Granted Patent US 8,251,071
Granted Patent B2
US 8,251,071 · App. 12/759,805 · Granted Aug 28, 2012

Powerhead of a power injection system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,251,071
App. No.
12/759,805
Granted
Aug 28, 2012
Kind
B2
Abstract

A contrast media injection system includes detects the absolute position of the syringe ram using a non-contact sensor. A series of magnets and Hall-Effect sensors may be used or an opto-reflective system. Illuminated knobs that are connected to the drive mechanism for the syringe ram rotate with the drive and provide visual feedback on operation through the illumination. Analog Hall-Effect sensors are used to determine the presence or absence of magnets that identify the type of faceplate being used. The faceplates include control electronics, connected to the powerhead through connectors, which may be interchangeably used by the two faceplates. The faceplate electronics include detectors for automatically detecting the capacity of pre-filled syringes. Additional features include using historical data to provide optimum pressure limit values during an injection protocol, a removable memory device for storing and transferring information such as injection protocols and injector statistics, and password protection of such protocols.

Claims (18)

1. A method of maintaining a contrast media injector system comprising a first remote console and a powerhead, said method comprising the steps of:

transferring data from said first remote console to said powerhead;

replacing said first remote console with a second remote console after said transferring step; and

transferring said data from said powerhead to said second remote console after said replacing step.

2. The method of claim 1 , wherein said data comprises programs for automatic injection.

3. The method of claim 1 , wherein said transferring step in relation to said first remote console comprises transferring said data from first remote console memory to powerhead memory.

4. The method of claim 3 , wherein said transferring step in relation to said second remote console comprises transferring said data from said powerhead memory to second remote console memory.

5. The method of claim 1 , wherein said transferring step in relation to said second remote console comprises transferring said data from powerhead memory to second remote console memory.

6. A method of maintaining a contrast media injector system comprising a remote console and a powerhead, said method comprising the steps of:

executing a first transferring step comprising transferring data from said powerhead to said remote console;

repairing said powerhead after said first transferring step; and

executing a second transferring step after said repairing step and comprising transferring said data from said remote console back to said powerhead.

7. The method of claim 6 , wherein said data comprises calibration parameters.

8. The method of claim 6 , wherein said first transferring step comprises transferring said data from powerhead memory to remote console memory.

9. The method of claim 8 , wherein said second transferring step comprises transferring said calibration parameters from said remote console memory back to said powerhead memory.

10. The method of claim 9 , wherein said repairing step comprises replacing a main circuit board of said powerhead.

11. The method of claim 8 , wherein said repairing step comprises replacing a main circuit board of said powerhead.

12. The method of claim 6 , wherein said repairing step comprises replacing a main circuit board of said powerhead.

Assignments (1)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →